Mori S, Lee E H
Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Int J Womens Dermatol. 2018 Sep 13;5(1):21-26. doi: 10.1016/j.ijwd.2018.08.001. eCollection 2019 Feb.
Patient-reported outcome measures (PROMs) are utilized in health care to quantify the patient's perspective of a health condition or treatment on outcomes, such as health-related quality of life (HRQoL) and patient satisfaction. In dermatology, this is particularly relevant because the patient's perspective is critical in evaluating the outcome of cosmetic procedures as well as skin cancer treatment. We review seven validated PROMs that have been reported in the dermatologic surgery and cosmetic dermatology literature. For patients undergoing cosmetic procedures, the use of PROMs provides additional valuable outcome data beyond physician assessment. For patients with skin cancer, women experience a unique and often greater impact on HRQoL during treatment, which has been captured through PROMs. The recent development of multi-module instruments, such as the FACE-Q and FACE-Q Skin Cancer, have facilitated comprehensive assessments of treatment that impact multiple domains of HRQoL. The use of PROMs allows for dermatologists to reliably capture important disease- and treatment-related concerns, thus improving the patient experience.
患者报告结局测量(PROMs)在医疗保健中用于量化患者对健康状况或治疗结果的看法,如健康相关生活质量(HRQoL)和患者满意度。在皮肤科,这一点尤为重要,因为患者的看法对于评估美容手术以及皮肤癌治疗的结果至关重要。我们回顾了七项在皮肤科手术和美容皮肤科文献中报道的经过验证的PROMs。对于接受美容手术的患者,使用PROMs可提供超出医生评估的额外有价值的结局数据。对于皮肤癌患者,女性在治疗期间对HRQoL会经历独特且往往更大的影响,这已通过PROMs得以体现。多模块工具的最新发展,如FACE-Q和FACE-Q皮肤癌工具,有助于对影响HRQoL多个领域的治疗进行全面评估。使用PROMs使皮肤科医生能够可靠地了解与疾病和治疗相关的重要问题,从而改善患者体验。